Saturday 17 October 2026 Export RARE’s income statement to Excel — free account

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $673.0 million, up 20.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.1%, EPS grew 23.1% and free cash flow grew 12.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

14.54 0.63 −4.15%

Follow RARE

Alert me

Market cap: $1.5B
P/E: 0.0×
Fwd P/E: −4.8×
Dividend yield: —
F-score: 5/9
Altman Z: −3.57
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(325.64%)	(657.14%)	1,327.47%	838.86%
Piotroski F-Score Full definition →		3	5	3	3
ROA Full definition →		(42.48%)	(37.89%)	(46.70%)	(45.60%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(104.79%)	(70.90%)	(106.65%)	(119.59%)
Average Days of Receivables Full definition →		65.14	85.69	65.92	101.81
Free Cash Flow per Share Full definition →		(4.67)	(4.94)	(5.05)	(4.85)
Free Cash Flow Full definition →		(466.21)	(487.00)	(508.00)	(494.00)
Capital Expenditures Full definition →		(20.72)	(21.00)	(11.00)	(9.00)
Other line items
Cash ROIC Full definition →		(107.32%)	(81.17%)	(287.01%)	(49,400.00%)
Accounts Receivable Turnover Full definition →		6.13	4.81	6.10	4.42
Accounts Payable Turnover Full definition →		2.54	3.11	2.46	3.30
Inventory Turnover Full definition →		2.03	2.25	2.18	2.29
Average Days of Payables Full definition →		152.42	103.81	139.36	117.64
Days of Inventory on Hand Full definition →		196.11	174.13	182.50	177.98
Tax Rate Full definition →		0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →		116.58%	111.44%	115.07%	107.81%
Selling, General and Administrative Expense of Revenue Full definition →		54.32%	51.86%	52.24%	48.95%
Share Based Compensation of Revenue Full definition →		24.71%	22.73%	21.34%	19.39%
Interest Coverage Full definition →		(9.44)	(8.63)	(8.13)	(6.86)
Operating CF/Net income Full definition →		0.77	0.81	0.82	0.83
Depreciation/Fixed assets Full definition →		0.12	0.13	0.13	0.13
Capex/Depreciation Full definition →		(0.71)	(0.68)	(0.35)	(0.29)
Revenue per Share Full definition →		6.32	6.83	6.66	7.04
Operating CF per Share Full definition →		(4.47)	(4.73)	(4.94)	(4.76)
Capex per Share Full definition →		(0.21)	(0.21)	(0.11)	(0.09)
Capex to Sales Full definition →		0.03	0.03	0.02	0.01

Show all line items

Columns are period end dates

Stockrow Weekly